Safety Monitoring of Herb-Drug Interactions Souad SkalliRachida Soulaymani Bencheikh Current Opinion 13 December 2012 Pages: 785 - 791
Pregabalin Treatment for Peripheral Neuropathic Pain Setsuro OgawaJo SatohMakoto Suzuki Review Article 13 December 2012 Pages: 793 - 806
Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting Jackie InchMargaret C. WatsonYellow Card Study Collaboration Systematic Review 13 December 2012 Pages: 807 - 818
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders Hoda MoteshafiSimon ZhornitskyEmmanuel Stip Systematic Review 13 December 2012 Pages: 819 - 836
Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance Centre Betsabé Sánchez-SánchezMarina Altagracia-MartínezJuan Manuel Martínez-Núñez Short Communication 13 December 2012 Pages: 837 - 844
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines Geneviéve DurrieuAurore PalmaroFrench Network of Pharmacovigilance Centres Original Research Article 13 December 2012 Pages: 845 - 854
Effect of Competition Bias in Safety Signal Generation Antoine ParientePaul AvillachAssociation Française des Centres Régionaux de Pharmacovigilance (CRPV) Original Research Article 13 December 2012 Pages: 855 - 864
Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations Xiwu LinDaniel ParksKwan Lee Original Research Article 13 December 2012 Pages: 865 - 875